TARRAH HOLLIDAY: Open Payments
NPI 1114521721 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150,815 in 255 payments from 9 companies in 2025. Trend: 2023 $121,825 · 2024 $123,071 · 2025 $150,815
Speaker / faculty: $109,050Travel & lodging: $24,049Consulting: $12,000Food & beverage: $5,717
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 239 | $150,500 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Lundbeck LLC | 3 | $55 |
| Corium, LLC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: LYBALVI, ARISTADA, REXULTI, Azstarys, CAPLYTA, ABILIFY MAINTENA, INGREZZA, INVEGA SUSTENNA.
Industry payments across IA — which companies pay providers there.
